Here’s Why Wall Street Still Sees Room in Labcorp (LH) Even After Its Run
Labcorp Holdings Inc. LH
$371.83
▲ +1.43%
(+$5.26)
Index member:
S&P 500
Open
$369.28
Prev Close
$366.57
Day Range
$364.79 – $373.76
52W Range
$244.52 – $373.34
Market Cap
$29.86B
P/E (TTM)
29.65
Beta
0.83
Div Yield
1.35%
EPS (TTM)
$12.19
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1991-04-24 |
| Shares Out. | 81,200,000 |
| Website | labcorp.com/ ↗ |
| Phone | 13362291127 |
| Employees | 71,000 |
| Revenue | $3.81B |
| Gross Profit | $1.11B |
| Net Income | $263.1M |
| Free Cash Flow | $1.29B |
| Total Assets | $18.92B |
| Total Liabilities | $10.06B |
| Equity | $8.86B |
About Labcorp Holdings Inc.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Labcorp Holdings Inc. is a publicly traded company under the ticker symbol LH on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
27 analysts (2026-11-01)
📰 Latest News for LH
Labcorp completes $375M Millennium Health takeover
Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics
Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Block, Cisco Systems, Dollar Tree, First Solar, HubSpot, JetBlue Airways, Nike, Space-X, Skyworks Solutions, and More
Myriad Genetics Q3 Earnings Call Highlights
Labcorp to Speak at the UBS Global Healthcare Conference
What Just Happened To Natera Stock?
Labcorp’s Q3 earnings call: our top 5 analyst questions

